Teoh, E, Bottomley, D, Scarsbrook, A orcid.org/0000-0002-4243-032X et al. (15 more authors) (2017) Impact of F-18-fluciclovine PET/CT on Clinical Management of Patients with Recurrent Prostate Cancer: Results from the Phase 3 FALCON Trial. In: International Journal of Radiation Oncology Biology Physics. 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), 24-27 Sep 2017, San Diego, CA, USA. Elsevier , pp. 1316-1317.
Abstract
When biochemical recurrence (BCR) of prostate cancer is suspected, early and accurate localization of metastases facilitates treatment when tumors are small and most amenable to localized therapy, and may guide clinicians in making management plans regarding salvage therapy. Here, we present results of a preplanned analysis of the FALCON trial (NCT02578940), which assessed the impact of PET/CT imaging with 18F-fluciclovine on clinical management choices for men with BCR of prostate cancer.
Metadata
Item Type: | Proceedings Paper |
---|---|
Authors/Creators: |
|
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Biomed & Clin Sciences (LIBACS) (Leeds) |
Depositing User: | Symplectic Publications |
Date Deposited: | 02 Jan 2018 13:29 |
Last Modified: | 02 Jan 2018 13:29 |
Status: | Published |
Publisher: | Elsevier |
Identification Number: | 10.1016/j.ijrobp.2017.09.015 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:125553 |